Invest in NightWise LLC

A Science-Backed Supplement for Healthy, Deep Sleep

EARLY BIRD TERMS: $55,247 LEFT

$64,750

raised from 9 investors
INVESTMENT TERMS
Priced Round
 $10M  $8.5M pre-money valuation
Early Bird Bonus: Investors who fund up to the first $120K of this fundraise will invest at a $8.5M pre-money valuation and a $4.95 price per share.
$250, $500, $1K, $2.5K, $5K, $10K, $20K

Highlights

1
NightWise® addresses a major problem: 60% worldwide report not getting enough quality sleep.
2
Our solution is backed by science and protected by our patented Intelligent Release Technology®.
3
$225,000+ in e-commerce revenue shows strong demand for our product.
4
Our team, with decades of experience from Coca-Cola, Solaray, and Nature’s Way, drives our growth.

Featured Investor

Our Team


The Sleep Revolution Has Arrived….

…and the world is ready for it. 

According to the National Sleep Foundation, up to 90 million Americans struggle to achieve a good night’s sleep. With increasing awareness of sleep's vital role in our health, more people are committed to improving their sleep quality.

Frequent business trips left our founder, Danny Rinaldi, constantly battling sleep deprivation. Realizing how widespread this struggle was, he set out to create a real solution. In his own basement, Danny personally bottled the first 1,000 bottles of NightWise® on a Saturday, driven by the belief that a better night’s sleep shouldn’t come with grogginess or dependency.

Despite the universal need for sleep, the sleep aid market has seen little innovation over the past 75 years. Partnering with Scott Forsberg—a leading nutraceutical scientist and former executive at major supplement companies like Nature's Way and Solaray—they developed NightWise®: multi-ingredient, advanced, controlled-release, drug-free, non-habit-forming sleep solution designed to align with the body’s natural sleep rhythms.

Backed by Science: NightWise®’s Intelligent Release Technology® 

NightWise® is the sleep aid designed to work with your body’s natural sleep rhythms, promoting uninterrupted sleep that balances REM and deep sleep cycles for optimal rest.

Our patented Intelligent Release Technology® gradually releases scientifically-backed ingredients, ensuring healthy, deep sleep without morning grogginess or dependency. Safe and non-habit forming, NightWise® can be used nightly or as needed to support consistent, healthy sleep patterns.

Each batch undergoes third-party testing to ensure purity, safety, and quality, so you can trust that what’s on the label is exactly what’s in the capsules.

With just one capsule before bed, NightWise® starts working from the first use, enhancing your sleep environment naturally and effectively.

Helping Thousands Get Better Sleep Without Traditional Pharmaceutical Sleep Aids

Our customers love NightWise®, and their testimonials highlight the profound impact the product has had on their lives. NightWise® offers millions of people a viable alternative to the side effects and risks of traditional sleep aids -which can include addiction, loss of efficacy and memory impairment. 

Revenue & Market Traction 

Following meticulous market research and product development, we soft-launched a D2C e-commerce platform to bring NightWise® to an audience looking for improved sleep. NightWise® stood out among its competitors in the sleep aid market, generating over $228,000 in cumulative sales in 2024, an indicator of our strong product-market fit and potential for exponential growth. 

The figures shown represent cumulative sales from inception through each year listed.

Compelling Unit Economics 

By shifting from a pharmaceutical-based manufacturer to a specialized dietary supplement partner, we’ve achieved a 61% reduction in Cost of Goods Sold (COGS). This strategic move allows us to deliver a high-quality, patented sleep solution at a competitive price—lowering our retail price from $48 to under $20 per bottle. This cost efficiency, combined with product differentiation, has strengthened our competitive position across retail and online markets, driving growth and accessibility.

Strategic Expansion and Future Growth

The market opportunity for NightWise® is vast and ripe for disruption. The global sleep market is projected to grow at a compounded annual growth rate (CAGR) of 6.8% through 2026, reaching a staggering $106 billion. Specifically, the over-the-counter sleep market in multi-unit retail outlets (MULO) is set to nearly double, approaching $2 billion by 2026.

New Product Lines

At NightWise®, we’re passionate about transforming sleep experiences for everyone. As a company at the forefront of the sleep health industry, we draw from deep consumer insights and our proven direct-to-consumer success to consistently introduce groundbreaking products. Our flagship NightWise® Sleep Formula, powered by our patented Intelligent Release Technology®, exemplifies this commitment to innovation. This superior formula promotes deep, healthy sleep and energized mornings. Along with our refreshed visual identity, NightWise® stands out on retail shelves, creating a powerful presence that reinforces our market leadership as we expand into retail.

Recognizing high-growth opportunities in the sleep market, we’re excited to launch two new targeted products: NightWise® Sleep + Menopause Night Relief, designed to ease hot flashes and night sweats for women, and NightWise® Sleep + Prostate Night Support, crafted to minimize nighttime awakenings for men. These drug-free, science-backed innovations reflect our dedication to addressing the root causes of sleep challenges. By consistently leading with transformative solutions, NightWise® continues to reshape the sleep health industry.

Nationwide Retail Expansion 

NightWise® is entering a major growth phase, evolving from e-commerce to a multi-channel brand with a strong retail presence. With the over-the-counter sleep aid market projected to reach $1.9 billion by 2026, NightWise® is positioned to capture a significant share by targeting high-demand retailers like CVS, Walgreens, Walmart, Target, Kroger, and Albertsons.

Since partnering with Market Solutions—a top retail brokerage firm with 30+ experienced professionals—we’re launching a controlled phased-in retail rollout. Our strategic entry will establish a foundation for long-term growth, aiming to capture 1% of the market (~$19M in revenue) by 2026, 2% ($40M) by 2027, and 3% ($57M) by 2028.

Our goal is to efficiently reach 20% of top chains in the next 6-12 months, expanding into 50% of Drug, Food, Mass Merchant, and Dollar Store channels over 24 months. Each dollar invested directly accelerates this expansion, secures new retail partnerships, and builds NightWise® into a leading name in sleep health, maximizing return potential.

Future projections are not guaranteed.

NightWise® is Poised for Massive Growth: $600,000 Needed to Revolutionize Sleep Health

Our early traction attracted a friends and family round from investors who believed in our vision. This investment, along with over $1M+ bootstrapped by our founders brought us to this critical moment in our growth.

We’re raising $600,000 to fund our retail expansion into a small number of early stores and launch two targeted products, NightWise® Sleep Plus Menopause Night Relief and Prostate Night Support. This will allow us to capture a larger market share and strengthen NightWise®’s position as a leader in sleep health.

By investing in NightWise®, you join a mission to bring healthy, deep sleep solutions to millions.


Overview